Evidence map›Paper›PMID 38212376›Full record

ReviewMolecular psychiatry2024

Roles of the medial and lateral orbitofrontal cortex in major depression and its treatment.

Bei Zhang, Edmund T Rolls, Xiang Wang, Chao Xie, Wei Cheng, Jianfeng Feng

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
20.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 73 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Brain network localization of anhedonia.Translational psychiatry · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 3 countries.

Bei Zhang *Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, PR China.ORCID 0000-0003-0845-7534
Edmund T Rolls *Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, PR China. Edmund.Rolls@oxcns.org.ORCID 0000-0003-3025-1292
Xiang WangMedical Psychological Center, The Second Xiangya Hospital, Central South University, Changsha, PR China.ORCID 0000-0001-9258-2017
Chao XieInstitute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, PR China.
Wei ChengInstitute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, PR China. wcheng@fudan.edu.cn.ORCID 0000-0003-1118-1743
Jianfeng FengInstitute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, PR China. jffeng@fudan.edu.cn.ORCID 0000-0001-5987-2258
Fudan University · CNCentral South University · CN

Funding

China Postdoctoral Science Foundation 2022M710804National Natural Science Foundation of China (National Science Foundation of China) 82071997Science and Technology Commission of Shanghai Municipality (Shanghai Municipal Science and Technology Commission) 2018SHZDZX01
6 · The paper itself

Abstract

We describe evidence for dissociable roles of the medial and lateral orbitofrontal cortex (OFC) in major depressive disorder (MDD) from structure, functional activation, functional connectivity, metabolism, and neurochemical systems. The reward-related medial orbitofrontal cortex has lower connectivity and less reward sensitivity in MDD associated with anhedonia symptoms; and the non-reward related lateral OFC has higher functional connectivity and more sensitivity to non-reward/aversive stimuli in MDD associated with negative bias symptoms. Importantly, we propose that conventional antidepressants act to normalize the hyperactive lateral (but not medial) OFC to reduce negative bias in MDD; while other treatments are needed to operate on the medial OFC to reduce anhedonia, with emerging evidence suggesting that ketamine may act in this way. The orbitofrontal cortex is the key cortical region in emotion and reward, and the current review presents much new evidence about the different ways that the medial and lateral OFC are involved in MDD.

Indexed as

AnhedoniaMajor Depressive DisorderPrefrontal CortexAntidepressive AgentsEmotionsHumansKetamineRewardAntidepressive AgentsKetamine

Identifiers

PMID38212376
OpenAlexW4390794856

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.